Patrick McCall
Director of Finance/CFO chez IN8BIO, INC.
Fortune : 31 571 $ au 31/03/2024
Profil
Patrick McCall is currently the Chief Financial Officer & Secretary at IN8bio, Inc. Prior to his current position, he worked as the Controller at Catalyst Biosciences, Inc. and as the Vice President-Finance at Turnstone Biologics Corp.
from 2018 to 2021.
Mr. McCall completed his undergraduate degree at Drexel University and holds an MBA from Cornell University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IN8BIO, INC.
0,06% | 07/02/2024 | 26 755 ( 0,06% ) | 31 571 $ | 31/03/2024 |
Postes actifs de Patrick McCall
| Sociétés | Poste | Début |
|---|---|---|
| IN8BIO, INC. | Director of Finance/CFO | 08/02/2021 |
Anciens postes connus de Patrick McCall
| Sociétés | Poste | Fin |
|---|---|---|
| TURNSTONE BIOLOGICS CORP. | Director of Finance/CFO | 01/02/2021 |
| CATALYST BIOSCIENCES | Comptroller/Controller/Auditor | - |
Formation de Patrick McCall
| Drexel University | Undergraduate Degree |
| Cornell University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| IN8BIO, INC. | Health Technology |
| TURNSTONE BIOLOGICS CORP. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Catalyst Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA. | Health Technology |
